Advertisement

Inherited Ichthyoses

  • Mourad Mokni
Chapter

Abstract

Inherited ichthyoses are a group of genetic disorders characterized by dry skin, hyperkeratosis, and increased scale desquamation, often associated with erythroderma. The clinical manifestations are due to a series of mutations of genes involved in the development of the stratum corneum and skin barrier formation. The group consists of phenotypic expressions limited only in the skin and its appendages and others with additional extracutaneous involvement. The incidence of ichthyotic conditions in pigmented and black skin ethnic populations is not known. In two reports from the Eastern Province of Saudi Arabia, the incidence of hereditary ichtyosis and non-bullous congenital ichthyosiform erythroderma has been assessed, respectively, 7 per 1000 and 2 per 1000 new patients. These relatively high rates may be attributed to high consanguinity in countries of the Middle East [1, 2]. The commonest type of hereditary ichthyosis was ichthyosis vulgaris followed by non-bullous ichthyosiform erythroderma; 90% of the patients in this group were born with collodion membranes. Also in populations in East Africa, ichthyoses are not rarely seen.

References

  1. 1.
    Al-Zayir AA, Al-Amro Al-Alakloby OM. Clinico-epidemiological features of primary hereditary ichthyoses in the eastern province of Saudi Arabia. Int J Dermatol. 2006;45:257–64.CrossRefPubMedGoogle Scholar
  2. 2.
    Al-Amro Al-Akloby OM, Al-Zayir AA. Clinico-epidemiological features of congenital nonbullous ichthyosiform erythroderma in the eastern province of Saudi Arabia. J Eur Acad Dermatol Venereol. 2004;18:659–64.CrossRefPubMedGoogle Scholar
  3. 3.
    Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyoses: results of the first Ichthyosis consensus conference in Soreze 2009. J Am Acad Dermatol. 2010;63:607–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Ibekwe PU, Ogunbiyi AO, Ogun OG, et al. Social stigmatization of two sisters with lamella ichthyosis in Ibadan, Nigeria. Int J Dermatol. 2012;51:67–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Sandilands A, Terron-Kwiatkowski A, Hull PR, et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet. 2007;39:650–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Taylan F, Nilsson D, Asad S, et al. Whole-exome sequencing of Ethiopian patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol. 2015;136:507–9.e519.CrossRefPubMedGoogle Scholar
  8. 8.
    Polcari I, Becker L, Stein SL, et al. Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis. Pediatr Dermatol. 2014;31:489–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Taylan F, Nilsson D, Asad S, et al. Whole-exome sequencing of Ethiopian patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol. 2015;136:507–9.e19.CrossRefPubMedGoogle Scholar
  10. 10.
    Khadir K, Benharbit B, Habibeddine S, et al. Treatment outcome for collodion babies: the experience of the dermatology Department of Ibn Rochd Teaching Hospital. Casablanca Ann Dermatol Venereol. 2009;136:731–2.CrossRefPubMedGoogle Scholar
  11. 11.
    Jacyk WK. Bathing-suit ichthyosis. A peculiar phenotype of lamellar ichthyosis in South African blacks. Eur J Dermatol. 2005;15:433–6.PubMedGoogle Scholar
  12. 12.
    Benmously-Mlika R, Zaouak A, Mrad R, et al. Bathing suit ichthyosis caused by a TGM1 mutation in a Tunisian child. Int J Dermatol. 2014;53:1478–80.CrossRefPubMedGoogle Scholar
  13. 13.
    Migowa AN, Murungi CW, Gatinu BW, et al. Harlequin ichthyosis in an African child: case report. East Afr Med J. 2010;87:389–92.PubMedGoogle Scholar
  14. 14.
    Glick JB, Craiglow BG, Choate KA, et al. Improved management of harlequin ichthyosis with advances in neonatal intensive care. Pediatrics. 2017;139(1).  https://doi.org/10.1542/peds.2016-1003.
  15. 15.
    Traupe H, Burgdorf WHC. Treatment of ichthyosis—there is always something you can do! In memoriam: Wolfgang Küster. J Am Acad Dermatol. 2007;57:542–7.CrossRefGoogle Scholar
  16. 16.
    Bassotti A, Moreno S, Criado E. Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis. Pediat Dermatol. 2011;28:451–5.CrossRefGoogle Scholar
  17. 17.
    Digiovanna JJ, Mauro T, Milstone LM, et al. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26:26–38.CrossRefPubMedGoogle Scholar
  18. 18.
    van Steensel MA. Emerging drugs for ichthyosis. Expert Opin Emerg Drugs. 2007;12:647–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Vahlquist A, Blockhuys S, Steijlen P, et al. Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial. Br J Dermatol. 2014;170:173–81.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Service der Dermatologie, Hopital La RabtaTunisTunisia

Personalised recommendations